Development of a Universal Anti-Adalimumab Antibody Standard for Interlaboratory Harmonization

BACKGROUND: Therapeutic drug monitoring of adalimumab (ADM) has been introduced recently. When no detectable ADM serum concentrations can be found, the formation of antidrug antibodies (ADA) should be investigated. A variety of assays to measure the occurrence of ADA have been developed. Results are...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ther Drug Monit
Päätekijät: Gils, Ann, Vande Casteele, Niels, Poppe, Raf, Van de Wouwer, Marlies, Compernolle, Griet, Peeters, Miet, Brouwers, Els, Vermeire, Séverine, Geukens, Nick, Declerck, Paul J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Therapeutic Drug Monitoring 2014
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218762/
https://ncbi.nlm.nih.gov/pubmed/24906181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000074
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia